You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-xa

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vasopressors on Anti-Xa Activity in Critically Ill Patients

Recruiting
  • Critical Illness
  • Thrombosis
  • Serum anti-Xa activity
  • Gdańsk, Poland
    Medical University of Gdańsk - Departament of Anesthesiology and
Sep 20, 2023

Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19

Completed
  • Critical Illness
  • +2 more
  • blood sampling
  • Arnhem, Netherlands
    Monique de Maat
Jun 28, 2023

LR-ACT and Anti Xa Activity During Endovascular Surgery

Not yet recruiting
  • Aortic Diseases
  • +2 more
  • Anti Xa activity measurement.
  • Bron, France
    Service de chirurgie vasculaire (U50) Hôpital Louis Pradel - HCL
Sep 21, 2022

Nephrotic Syndrome Trial in Warsaw (Enoxaparin)

Terminated
  • Nephrotic Syndrome
  • Warsaw, Masovian District, Poland
    Military Institute of Medicine
Jan 26, 2023

Anticoagulants and Bleeding Disorders, Surgery, Regional Anesthesia Morbidity Trial in Winston-Salem (Enoxaparin)

Terminated
  • Anticoagulants and Bleeding Disorders
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Baptist Medical Center
Dec 4, 2022

Venous Thromboembolism Trial (Peak value anti-Xa, Trough value anti-Xa, Control Group)

Not yet recruiting
  • Venous Thromboembolism
  • Peak value anti-Xa
  • +2 more
  • (no location specified)
May 15, 2022

Dose Regimen of Intravenous Unfractionated Heparin and Low

Active, not recruiting
  • COVID-19
  • +3 more
  • Gent, Belgium
    Ghent University Hospital
Oct 24, 2022

Anti-Xa Activity Trial in Vancouver (apixaban)

Terminated
Has Results
  • Anti-Xa Activity
  • Vancouver, British Columbia, Canada
    Vancouver General Hospital
Jul 28, 2021

Dose Adjustment of Enoxaparin in ICU Patients Trial in Kfar Saba (Dose adjustment of Enoxaparin in patients with sub-therapuetic

Completed
  • Dose Adjustment of Enoxaparin in ICU Patients
  • Dose adjustment of Enoxaparin in patients with sub-therapuetic (prophylactic) levels of factor 10a
  • Kfar Saba, Israel
    Meir Medical Center
Jan 23, 2022

Is Anti-Factor Xa Associated With Outcome in Critical COVID-19

Completed
  • Covid19
  • +2 more
  • The effect of LMWH
  • Monitoring frequency of aFXa-levels
  • Stockholm, Sweden
    Södersjukhuset
Feb 24, 2022

Traumatic Injury, Venous Thromboembolism Trial in Cincinnati (Enoxaparin 40 mg q12h, Enoxaparin 30 mg q8h)

Completed
Has Results
  • Traumatic Injury
  • Venous Thromboembolism
  • Enoxaparin 40 mg q12h
  • Enoxaparin 30 mg q8h
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Oct 22, 2021

Dextran Sulphate on Anti-Xa Activities Measured

Completed
  • Unfractionated Heparin Treatment
  • measurement of anti-Xa activities
  • Bordeaux, France
  • +7 more
Feb 8, 2021

Precision Medicine Platform for Novel Oral Anticoagulants

Recruiting
  • Anticoagulant Adverse Reaction
  • Pharmacogenomics
  • Kaohsiung, Taiwan
    Kaohsiung Medical University Hospital
Aug 30, 2021

Deep Vein Thrombosis, Pulmonary Embolism, Venous Thromboembolism Trial in Salt Lake City (Standard heparin dose, Real time

Unknown status
  • Deep Vein Thrombosis
  • +2 more
  • Standard heparin dose
  • Real time heparin dose adjustment
  • Salt Lake City, Utah
    University of Utah
Nov 11, 2020

Venous Thromboembolism, Pulmonary Embolism, Thromboprophylaxis Trial in Tampere (Enoxaparin)

Recruiting
  • Venous Thromboembolism
  • +2 more
  • Tampere, Pirkanmaa, Finland
    Tampere University Hospital
Feb 25, 2021

Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving

Not yet recruiting
  • Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis
  • Assessment the activity of anti-Xa factor.
  • Gdańsk, Pomorskie, Poland
    Medical University of Gdansk - Departament of Anesthesiology and
Dec 15, 2020

Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and

Unknown status
  • Anticoagulation
  • +2 more
  • Estimated anticoagulant level (conversion factor x anti-Xa activity)
  • (no location specified)
Nov 30, 2020

Heparin Requirements in Patients Undergoing Atrial Fibrillation

Completed
  • Atrial Fibrillation
  • Monitoring Anti Factor Xa level
  • Brighton, Massachusetts
    St Elizabeth Medical Center
Jul 15, 2021

Specific PoC Testing of Coagulation in Patients Treated With

Recruiting
  • Anticoagulation With NOAC
  • anti-Xa activity point-of-care testing (aXa-POCT)
  • ecarin clotting time point-of-care testing (ECT-POCT)
  • Tuebingen, Germany
    University Hospital Tuebingen
Dec 14, 2020

Unfractionated Heparin in COVID-19 and Non-COVID-19 Patients

Recruiting
  • Heparin Overdose of Undetermined Intent
  • COVID-19
  • Unfractionated heparin
  • Leiden, Zuid-holland, Netherlands
    Leiden University Medical Centre
Aug 19, 2022

Acute Coronary Syndrome Trial in Monastir (LOVENOX, ENOXAMED)

Completed
  • Acute Coronary Syndrome
  • Monastir, Tunisia
    Emergency Department of University Hospital of Monastir
Jul 20, 2020

Pediatric Kidney Transplant Recipients Trial in Paris (Bayesian based dose adjustment of enoxaparin, Usual dose adjustment of

Not yet recruiting
  • Pediatric Kidney Transplant Recipients
  • Bayesian based dose adjustment of enoxaparin
  • Usual dose adjustment of enoxaparin
  • Paris, Ile-de-France, France
    Hôpital Necker - Enfants malades
Jan 23, 2023

Anticoagulation in Patients on ECMO for Severe Lung Failure

Completed
  • ARDS
  • COVID-19
  • Ostrava, Moravian-Silesian Region, Czechia
    University Hospital Ostrava
Sep 18, 2023

'CTR' Ratio With Standard Haemostasis Parameters in Follow-up of

Recruiting
  • Venous Thromboembolic Disease
    • Saint-Mandé, France
      HIA Bégin
    Aug 7, 2023

    Symptomatic Aortic Stenosis, Eligible for Transcatheter Aortic Valve Replacement Trial in Worldwide (Apixaban, Standard of care)

    Completed
    • Symptomatic Aortic Stenosis
    • Eligible for Transcatheter Aortic Valve Replacement
    • Paris, France
    • +3 more
    Feb 24, 2021